January 2012 Issue of MMM
January 2012 issue
Each year we are asked by many people how we arrive at our choices for the MM&M All-Stars. Here 's how we make those decisions.
Company of the Year: Boehringer Ingelheim. From left: President/CEO Greg Behar; David Pass, VP, US pipeline marketing; and Kathleen Dowd, VP, respiratory marketing
Agency/Network of the Year: ICC Lowe. From left: Steve Viviano, CEO; Chet Moss, chief creative officer; Paul O'Neil, president, ICC Lowe
Large Pharma Marketing Team of the Year: Victoza. From left: John Spera, brand director, Victoza PCP marketing; Will Bainbridge, VP, Victoza brand; and Jeff Fayer, ...
Small Pharma Marketing Team of the Year: Incivek. From left: Pamela Stephenson, VP of marketing in charge of Incivek brand; Paul Daruwala, VP of marketing/HCV ...
Media Brand of the Year: Medical Economics. From left: EVP, chief administrative officer Tom Ehardt, and EVP Georgiann Decenzo
Makena, KV Pharma's drug for preventing preterm birth, has been no bundle of joy. In an exclusive interview, Noah Pines finds how the firm has ...
Some analysts predict that over half of all calls by 2015 will be fielded by NPs, PAs and others
The odds on the risks surrounding Plan B change when a teen is not under a doctor's supervision
Everyone in biopharma knows that manufacturers are spending more to develop drugs that earn less than they did ten years ago, but a new study ...
AstraZeneca is slashing its US sales force by 24% as it confronts a steep patent cliff.
Ipsen announced plans to reorganize its North American commercial operation by relocating the head office from California to New Jersey and hiring about 100 employees.
News on the US Supreme Court, Publicis Touchpoint Solutions, Trinity Pharma and Qforma
Med Ed Report
Pfizer is changing the way it funds medical education to make smarter use of shrinking funding and enhance the impact of activities, the firm said.
Pri-Med is under new ownership following M|C Holding's sale of the US assets to closely held Canadian event and media producer Diversified Business Communications.
News on FDA, ProMed Communications, Pfizer, Plannernet, and The Alliance for CME
FDA commissioner Margaret Hamburg's final decision to rescind Avastin's indication for metastatic breast cancer came in November. But ad spending to support the brand had ...
More than eight out of 10 pharma-sponsored clinical trials made it into a peer-reviewed journal, a 23% increase over the 2008 rate, researchers showed.
Plastic and Reconstructive Surgery
News on the American Academy of Neurology, Elsevier, Nature Publishing Group, The Female Patient and Wolters Kluwer Health
Several clients consolidated their advertising and promotion business last year, awarding all-in-one agency-of-record status for franchises, often including media duties. Should we expect more consolidations ...
Health information site HealthCentral has been acquired by Remedy Health, a multimedia provider of content and tools designed to help people manage disease, the firms ...
Facebook shut down Facebook.com/Merck after Merck KGaA announced plans to take legal action "based on the apparent takeover of its Facebook page" by its US ...
News on the American Academy of Family Physicians, the AMA, HealthiNation and Siemens Healthcare
Sanofi Pasteur launched an education campaign aimed at blunting increasing skepticism of childhood vaccinations.
AstraZeneca has taken a leaf from the traditional OTC analgesic playbook to position their latest NSAID, VIMOVO
A Manhattan Research survey found that "nearly two in five online Europeans would like to be able to learn more about prescription drugs directly from ...
Pfizer Oncology has recruited Desperate Housewives and West Wing star Kathryn Joosten for Lung Cancer Profiles, a national education campaign which aims to reduce stigma ...
Janssen Biotech wrapped up its IBD Icons campaign last month with American Idol's Casey Abrams crowning the winners of the user-generated content contest at a ...
News on New York-Presbyterian Hospital, Partners + Simons and AstraZeneca
Research giant GfK said it is acquiring Knowledge Networks, a provider of digital research in the US. The acquisition, terms of which were not disclosed, ...
A UK proposal to make anonymous patient data available for pharma company research elicited cheers and jeers.
GSW Worldwide co-founder Bob Gerbig has died at 66.
Euro RSCG released its annual crystal-ball-gazing white paper, "The Big Little Book of Nexts: Trendspotting for 2012," in October.
News on Merz, Novartis, Cooney/Waters Group, Edgemont Pharmaceuticals and Palio
Watching pharma executives, sometimes you have to wonder, "Will these guys ever learn?" Case in point, industry's assault on the FDA's conflict-of-interest rules.
FDA director of drugs Janet Woodcock says she is so optimistic that biomedical science and the war on cancer will produce "startlingly better" therapies that ...
Researchers are urging Congress to extend the exclusivity period for branded drugs by seven years and remove the initial 180-day marketing exclusivity granted to first-to-file ...
To meet new demands, many companies are restructuring—and need agencies who are doing the same. So for healthcare communications companies, the message is clear: adapt ...
Helayne Spivak of Saatchi & Saatchi Wellness looks at some recent print ads that take a smart and original approach to their material
At Work With
Tim Edbrooke, President and COO, Healogix
Name That Brand
Name That Brand for February
Whether or not Obamacare survives in court, the cost-control squeeze is going to intensify
This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.
- Novartis psoriasis drug approval could upend market
- Sandoz gets ready to make the biosimilar case with oncologists
- Guidemark Health jumpstarts rebrand, brings on big-agency grad
- MM&M's 5 minutes with: Mark Rothera, chief commercial officer, PTC Therapeutics
- Nurse practitioner workforce has just about doubled